Venture Capital

We provide sophisticated, pragmatic advice on venture capital investment transactions, acting for both investors and companies, at all stages from seed to exit.

Our international network of venture capital experts across Europe, Asia and the Middle East provides multi-disciplinary advice across the full spectrum of venture capital and growth equity transactions.

We support clients from seed and Series A funding rounds through to exit, whether via IPO or M&A, delivering commercially focused guidance at every stage of the investment lifecycle.

Our team regularly advises companies and their boards on the legal and strategic considerations involved in “down round” financings and distressed scenarios, helping them navigate complex challenges with confidence.

We review and negotiate financing documentation with a clear focus on future liquidity events, ensuring that terms align with long-term business objectives and investor expectations.

We are adept at managing substantive issues that arise during due diligence, including patent and licensing matters, employment concerns, pending litigation, outstanding debt instruments, real estate transactions, and other material agreements that may impact deal execution.

Our multidisciplinary teams, including experts in M&A, IP, data privacy, regulatory, tax, finance, funds, employment, real estate, technology and IP, work together towards a common goal: our clients’ success.

Market recognition

“Simmons & Simmons has a very good understanding of current practice and provides good quality commercial advice. They were good at finding solutions and not merely highlighting problems and risks.”

Chambers UK 2026, Corporate/M&A

“They provide timely, considered and pragmatic advice and are well resourced across disciplines.”

Chambers UK 2026, Investment Funds

Our experience

Legal and General

Investments in PQ Shield and Ultromics

East Alpha

Investments in Signol, Kobi.ai, DigiLab, Electron, Luffy AI, ToffeeAM and Unicorn Biotechnologies

Investor syndicate

Series C investment in Tokamak Energy